102460 — Reyon Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSucker Stock

Market Cap
KR₩205bn
Enterprise Value
KR₩415bn
Revenue
KR₩146bn

Annual balance sheet for Reyon Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	97,448	36,069	24,241	10,215	6,782
Net Total Accounts Receivable
Net Total Receivables	40,850	42,048	39,978	37,162	34,680
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	164,804	109,006	99,813	89,443	79,665
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	281,156	340,568	368,342	384,397	361,230
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	477,978	484,692	499,776	499,994	465,100
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	47,503	47,951	125,602	135,537	143,331
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	232,741	236,926	251,151	250,053	244,827
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	245,237	247,765	248,625	249,941	220,273
Total Liabilities & Shareholders' Equity	477,978	484,692	499,776	499,994	465,100
Total Common Shares Outstanding
Total Preferred Shares Outstanding